Catheter-based sympathetic renal denervation (RDN) is a novel iteration of a historical but effective treatment for hypertension. A number of different device systems have demonstrated a ...

The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...

A minimally invasive procedure used to treat resistant hypertension or high blood pressure that does not respond to other ...

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...

The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November 2023. It is indicated to reduce blood pressure as an adjunctive treatment ...

Against this backdrop, catheter-based renal denervation (RDN) has emerged as a novel interventional strategy for the management of treatment-resistant hypertension. RDN involves the selective ...

Renal denervation works by changing how the sympathetic nervous system around the kidneys, or renal sympathetics, communicates with the brain, eliminating the feedback that says blood pressure needs ...

Second, the AoCo model might be accompanied by elevated arterial carotid and aortic baroreceptor activation which might suppress the normal vasomotor and renal sympathetic tone ... and renal ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for ...